发明名称 Methods for the controlled delivery of pharmacologically active compounds
摘要 The present invention provides compositions and methods for extending the release times and lowering the toxicity of pharmacologically active compounds. The compounds comprise a salt of the pharmacologically active compound with a lipophilic counterion and a pharmaceutically acceptable water soluble solvent combined together to form an injectable composition. The lipophilic counterion may be a saturated or unsaturated C<SUB>8</SUB>-C<SUB>22 </SUB>fatty acid, and preferably may be a saturated or unsaturated C<SUB>10</SUB>-C<SUB>18 </SUB>fatty acid. The compounds precipitate in aqueous environments. When injected into a mammal, at least a portion of the composition precipitates and releases the active compound over time. Thus, the composition forms a slowly releasing drug depot of the active compound in the mammal. Therefore, the present invention enables one to provide a controlled dose administration of the active compound for a period of up to 15 days or even longer. Many compounds can be administered according to the present invention including, but not limited to, tilmicosin, oxytetracycline, metoprolol, fluoxetine, roxithromycin, and turbinafine.
申请公布号 US6946137(B2) 申请公布日期 2005.09.20
申请号 US20030418946 申请日期 2003.04.18
申请人 IDEXX LABORATORIES, INC. 发明人 MURTHY YERRAMILLI V. S. N.;SUVA ROBERT H.
分类号 A61K;A61K9/00;A61K31/65;A61K47/10;A61K47/12;A61K47/14;A61K47/20;A61K47/22;A61K47/26;(IPC1-7):A61K9/00 主分类号 A61K
代理机构 代理人
主权项
地址